Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Dalsspira Mejeri SPIRA Apr 13, 2021 2.98 +1.36   
 DanCann Pharma DANCAN Apr 13, 2021 4.14 +1.22   
 DDM Holding DDM Apr 13, 2021 28.20 0.00   
 Dedicare B DEDI Apr 13, 2021 58.40 +1.04   
 Desenio DSNO Apr 13, 2021 93.00 0.00   
 DevPort DEVPB Apr 13, 2021 20.60 -1.44   
 DexTech Medical DEX Apr 13, 2021 45.00 0.00   
 Diadrom Holding DIAH Apr 13, 2021 11.40 0.00   
 Diamyd Medical B DMYDB Apr 13, 2021 27.10 +3.28   
 Dicot DICOT Apr 13, 2021 1.16 -0.68   
 Dignitana DIGN Apr 13, 2021 7.30 0.00   
 DistIT DIST Apr 13, 2021 89.20 +2.53   
 Dividend Sweden B DIVIB Apr 13, 2021 2.40 +23.08   
 Divio Technologies B DIVIOB Apr 13, 2021 2.46 -1.41   
 Diös Fastigheter DIOS Apr 13, 2021 78.00 +1.63   
 DNB DNBO Apr 13, 2021 185.60 0.00   
 DNO DNOO Apr 13, 2021 9.15 0.00   
 DOF DOFO Apr 13, 2021 0.76 0.00   
 Dome Energy DOME Apr 13, 2021 2.90 +0.35   
 Dometic Group DOM Apr 13, 2021 128.55 +1.26   
 Doro DORO Apr 13, 2021 58.20 -0.34   
 Double Bond Pharmaceutical B DBPB Apr 13, 2021 1.99 +0.10   
 Doxa DOXA Apr 13, 2021 2.24 +0.90   
 Drillcon DRIL Apr 13, 2021 9.98 0.00   
 Duni DUNI Apr 13, 2021 108.60 +0.74   
 Duroc B DURCB Apr 13, 2021 29.60 +0.34   
 Dustin Group DUST Apr 13, 2021 109.50 +17.43   
 Eastnine EAST Apr 13, 2021 124.40 -0.48   
 EasyFill B EASYB Apr 13, 2021 1.85 -3.39   
 EatGood EATG Apr 13, 2021 2.17 -7.27   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK